Home » Topics » Regulatory » Patents

Patents
RSS

Green Cross describes inhibitors of lipid oxidation

Nov. 15, 1996

New hypolipidemic agents described by Nippon Zoki

Nov. 15, 1996

ADIR claims new agents for treating bone resorption

Nov. 15, 1996

Potent new antitumor agents revealed by Takeda

Nov. 15, 1996

Eisai discloses antitumor compounds

Nov. 15, 1996

Antineoplastic tyrosine kinase inhibitors disclosed by Thomae

Nov. 15, 1996

HIV protease inhibitors described by DuPont

Nov. 15, 1996

Novel antibacterial compound from Banyu

Nov. 15, 1996

New NK1 antagonists claimed by Takeda

Nov. 15, 1996

Anti-H. pylori antisense oligonucleotides reported by SCRAS

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...